Company has spent 5.29% of its operating revenues towards interest expenses and 11.24% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Tejnaksh Healthcare Share Price
Tejnaksh Healthcare Sha...
Tejnaksh Healthcare share price insights
Stock gave a 3 year return of -44.25% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Stock generated -44.25% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
Tejnaksh Healthcare Ltd. share price moved down by -1.76% from its previous close of Rs 24.94. Tejnaksh Healthcare Ltd. stock last traded price is 24.50
Share Price Value Today/Current/Last 24.50 Previous Day 24.94
Key Metrics
PE Ratio (x) | 22.93 | ||||||||||
EPS - TTM (₹) | 1.07 | ||||||||||
MCap (₹ Cr.) | 49.77 | ||||||||||
Sectoral MCap Rank | 39 | ||||||||||
PB Ratio (x) | 2.09 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 5.00 | ||||||||||
Beta Beta
| -0.51 | ||||||||||
VWAP (₹) | 24.84 | ||||||||||
52W H/L (₹) |
Tejnaksh Healthcare Share Price Returns
1 Day | -1.76% |
1 Week | 2.17% |
1 Month | -4.3% |
3 Months | -15.46% |
1 Year | -28.0% |
3 Years | -44.25% |
5 Years | -21.22% |
Tejnaksh Healthcare News & Analysis
Tejnaksh Healthcare Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Tejnaksh Healthcare Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Employee & Interest Expense
Company has spent 5.29% of its operating revenues towards interest expenses and 11.24% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 3.20 2.99 3.21 3.17 3.11 Total Income Growth (%) 6.80 -6.76 1.10 2.22 11.14 Total Expenses 2.28 2.24 2.30 2.19 2.73 Total Expenses Growth (%) 1.74 -2.82 5.44 -20.04 8.85 EBIT 0.92 0.75 0.91 0.99 0.37 EBIT Growth (%) 21.87 -16.78 -8.48 165.55 31.36 Profit after Tax (PAT) 0.60 0.46 0.54 0.58 0.16 PAT Growth (%) 30.34 -15.45 -6.54 262.90 - EBIT Margin (%) 28.72 25.17 28.20 31.15 11.99 Net Profit Margin (%) 18.63 15.26 16.84 18.21 5.13 Basic EPS (₹) 0.29 0.24 0.27 0.28 0.08 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 31.35 31.23 29.61 24.57 24.91 Total Assets Growth (%) 0.41 5.46 20.49 -1.35 11.87 Total Liabilities 7.15 8.81 9.01 6.81 9.22 Total Liabilities Growth (%) -18.83 -2.20 32.32 -26.20 5.70 Total Equity 24.20 22.42 20.60 17.76 15.68 Total Equity Growth (%) 7.97 8.81 15.96 13.26 15.85 Current Ratio (x) 4.22 3.82 2.94 1.89 3.77 Total Debt to Equity (x) 0.17 0.27 0.31 0.24 0.43 Contingent Liabilities 0.00 - - - - All figures in Rs Cr, unless mentioned otherwise
Insights
Decrease in Cash from Investing
Company has used Rs 1.01 cr for investing activities which is an YoY decrease of 27.89%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 4.01 2.12 9.21 1.18 1.16 Net Cash used in Investing Activities -1.01 -1.40 -10.59 1.56 -1.21 Net Cash flow from Financing Activities -2.26 -1.20 1.62 -2.80 0.10 Net Cash Flow 0.74 -0.48 0.24 -0.06 0.05 Closing Cash & Cash Equivalent 1.72 0.99 1.47 1.23 1.29 Closing Cash & Cash Equivalent Growth (%) 73.08 -32.44 19.35 -4.72 4.36 Total Debt/ CFO (x) 1.03 2.77 0.68 3.54 5.68 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 7.48 7.73 13.57 11.85 13.70 Return on Capital Employed (%) 10.12 10.53 15.15 13.86 16.08 Return on Assets (%) 5.62 5.38 9.19 8.35 8.39 Interest Coverage Ratio (x) 6.09 6.57 10.35 6.31 4.90 Asset Turnover Ratio (x) 0.39 0.39 0.30 48.67 67.27 Price to Earnings (x) 26.74 41.67 62.89 36.10 17.51 Price to Book (x) 2.00 3.22 8.53 4.27 2.40 EV/EBITDA (x) 12.11 18.37 35.71 20.09 9.65 EBITDA Margin (%) 32.24 34.06 38.65 32.19 26.14
Tejnaksh Healthcare Peer Comparison
Tejnaksh Healthcare Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -44.25% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs BSE Healthcare
Stock generated -44.25% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -44.25% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs BSE Healthcare
Stock generated -44.25% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Tejnaksh Healthcare Board Meeting/AGM
Tejnaksh Healthcare Dividends
- Others
Meeting Date Announced on Purpose Details Aug 14, 2024 Aug 06, 2024 Board Meeting Quarterly Results May 28, 2024 May 21, 2024 Board Meeting Audited Results Feb 12, 2024 Feb 05, 2024 Board Meeting Quarterly Results Nov 11, 2023 Nov 02, 2023 Board Meeting Quarterly Results Sep 21, 2023 Aug 30, 2023 AGM A.G.M. Dividend announcements are not available.
All Types Ex-Date Record Date Announced on Details Splits Jul 19, 2023 Jul 19, 2023 May 20, 2023 Split: Old FV10.0| New FV:5.0 Bonus Apr 26, 2018 Apr 28, 2018 Mar 12, 2018 Bonus Ratio: 36 share(s) for every 10 shares held Bonus Mar 08, 2017 Mar 09, 2017 Jan 18, 2017 Bonus Ratio: 1 share(s) for every 1 shares held
About Tejnaksh Healthcare
Tejnaksh Healthcare Ltd., incorporated in the year 2008, is a Small Cap company (having a market cap of Rs 49.77 Crore) operating in Hospitals & Allied Services sector. Tejnaksh Healthcare Ltd. key Products/Revenue Segments include Hospital Services, Medicines and Other Operating Revenue for the year ending 31-Mar-2023. Show More
Executives
Auditors
- AV
Ashish Vishwas Rawandale
Chairperson & Executive DirectorPAPreeti Ashish Rawandale
Non Exe.Non Ind.DirectorSBSanjay Bhikajirao Khatal
Non Exe.Non Ind.DirectorKMKiran Madhavrao Pawar
Ind. Non-Executive DirectorShow More - P D Dalal & Co
Industry
Key Indices Listed on
-
Address
A 601, Floor No.6,Kailash Business Park,Veer Savarkar Marg,Mumbai, Maharashtra - 400079
More Details
Trending in Markets
Tejnaksh Healthcare Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.